Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q81294608)
Watch
English
Early clinical data and potential clinical utility of novel histone deacetylase inhibitors in prostate cancer
scientific article published on 01 September 2005
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16197607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16197607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
title
Early clinical data and potential clinical utility of novel histone deacetylase inhibitors in prostate cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16197607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16197607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
main subject
prostate cancer
1 reference
based on heuristic
inferred from title
publication date
1 September 2005
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16197607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16197607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
published in
Clinical prostate cancer
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16197607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16197607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
volume
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16197607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16197607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16197607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16197607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
page(s)
83-85
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16197607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16197607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
cites work
Epigenetic changes in prostate cancer: implication for diagnosis and treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1540-0352%2811%2970115-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Histone deacetylases and cancer: causes and therapies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1540-0352%2811%2970115-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical development of histone deacetylase inhibitors as anticancer agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1540-0352%2811%2970115-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1540-0352%2811%2970115-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1540-0352%2811%2970115-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1540-0352%2811%2970115-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1540-0352%2811%2970115-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1540-0352%2811%2970115-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1540-0352(11)70115-9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16197607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16197607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
PubMed publication ID
16197607
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16197607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16197607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit